You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Sitowise: Waiting for a turnaround
Sitowise is going through challenges which are partly market-driven, but attention is also increasingly turning to the company's own performance, particularly in view of the ongoing challenges in Sweden. Analyst Olli Koponen tells more about the company in this interview.
Content:
00:00 Intro
00:17 What does Sitowise do?
01:00 Market situation and Sitowise’s profitability
03:34 When can we expect a profitability turnaround?
05:38 Valuation
Herantis Pharma as an Investment | Life Science Night Dec. 2, 2024
Aiforia as an Investment | Life Science Night Dec. 2, 2024
Faron Pharmaceuticals as an Investment | Life Science Night Dec. 2, 2024
Life Science Companies as Investments | Life Science Night Dec. 2, 2024
Life Science Night | December 2, 2024
View all videos